Evidence map›Paper›PMID 40368950›Full record

ArticleNPJ Parkinson's disease2025

Differential memory enrichment of cytotoxic CD4 T cells in Parkinson's disease patients reactive to α-synuclein.

Antoine Freuchet, Emil Johansson, April Frazier, Irene Litvan, Jennifer G Goldman, Roy N Alcalay, David Sulzer, Cecilia S Lindestam Arlehamn, Alessandro Sette

Abstract read
In one paragraph

Article in NPJ Parkinson's disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Antoine FreuchetCenter for Autoimmunity and Inflammation, La Jolla Institute for Immunology, La Jolla, CA, USA.
Emil JohanssonCenter for Autoimmunity and Inflammation, La Jolla Institute for Immunology, La Jolla, CA, USA.
April FrazierCenter for Autoimmunity and Inflammation, La Jolla Institute for Immunology, La Jolla, CA, USA.
Irene LitvanDepartment of Neuroscience, University of California San Diego, La Jolla, CA, USA.
Jennifer G GoldmanJPG Enterprises LLC; prior: Shirley Ryan Ability Lab and Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Roy N AlcalayDepartment of Neurology, Columbia University Irving Medical Center, New York, NY, USA.
David SulzerAligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, USA.
Cecilia S Lindestam ArlehamnCenter for Autoimmunity and Inflammation, La Jolla Institute for Immunology, La Jolla, CA, USA.
Alessandro SetteCenter for Autoimmunity and Inflammation, La Jolla Institute for Immunology, La Jolla, CA, USA. alex@lji.org.

Funding

NovaSeq5000 High Throughput SequencerS10OD025052 · OD · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI SEUMOIS, GREGORY · 2018 to 2018
$832k
Aligning Science Across Parkinson's ASAP-000375Kyowa Kirin, Inc. KKNA-Kyowa Kirin North AmericaNIH HHS S10 OD025052Vetenskapsrådet 2024-00175
6 · The paper itself

Abstract

Parkinson's disease (PD) is a complex neurodegenerative disease with a largely unknown etiology. Although the loss of dopaminergic neurons in the substantia nigra pars compacta is the pathological hallmark of PD, neuroinflammation also plays a fundamental role in PD pathology. We have previously reported that PD patients have increased frequencies of T cells reactive to peptides from α-synuclein (α-syn). However, not all PD participants respond to α-syn. Furthermore, we have previously found that CD4 T cells from PD participants responding to α-syn (PD_R) are transcriptionally distinct from PD participants not responding to α-syn (PD_NR). To gain further insight into the pathology of PD_R participants, we investigated surface protein expression of 11 proteins whose genes had previously been found to be differentially expressed when comparing PD_R and healthy control participants not responding to α-syn (HC_NR). We found that Cadherin EGF LAG seven-pass G-type receptor 2 (CELSR2) was expressed on a significantly higher proportion of CD4 effector memory T cells (T

Identifiers

PMID40368950
PMCPMC12078614

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.